Rosuvastatin (Crestor)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Rosuvastatin (Crestor)
ATI class: Antilipidemic / HMG-CoA reductase inhibitor
Action
- ATI/source-folder candidate for Rosuvastatin (Crestor); verify mechanism against the source table before validation.
Therapeutic use
- Review under Antilipidemics medication safety.
Nursing assessment
- Assess muscle pain, weakness, dark urine, liver labs, renal function, lipid response, and pregnancy status.
- Review alcohol use, liver disease, and interacting medications.
- Assess adherence and diet/activity teaching needs.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Myopathy
- Rhabdomyolysis
- Liver enzyme elevation
- Proteinuria/hematuria reports in selected clients
- GI upset
Interactions
- Cyclosporine
- Gemfibrozil
- Warfarin monitoring may be affected
- Niacin
- Antacids can reduce absorption if taken together
Contraindications
- See source-specific contraindications and precautions before administration.
Precautions
- Pregnancy, breastfeeding, active liver disease, or unexplained persistent liver enzyme elevation.
- Use caution with renal impairment, older adults, hypothyroidism, and interacting lipid medications.
Client teaching
- Report muscle pain, severe weakness, fever, or dark urine.
- Separate antacids if instructed.
- Keep follow-up lipid and lab appointments.
- Avoid pregnancy while taking unless prescriber provides updated individualized guidance.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Dark urine with muscle symptoms is priority.
- Renal impairment can increase concern for statin-associated muscle injury.
- Statin therapy is prevention, not acute chest pain relief.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Lowers cholesterol production or improves lipid profile to reduce long-term plaque and vascular risk.
ATI medication interaction concept.
ATI medication class concept.
ATI medication nursing assessment concept.
ATI medication nursing assessment concept.
ATI medication mechanism of action concept.
ATI medication client teaching concept.
ATI medication interaction concept.
ATI medication nclex priority cue concept.
ATI medication interaction concept.
ATI medication adverse effect concept.
ATI medication class concept.